Ann: Long Covid-19 Collaboration Outcomes Presentation, page-70

If we dream big and ATL1102 will be used for LC and DMD of course it will add immense value to the company.

But, does anyone have a glimpse on what a scale up of production of ATL1102 for LC would mean in terms of pricing for the medicine?
People are talking about an annual cost of 100k USD or so for DMD treatment, but with LC we should reach prices in the range of Aspirin.
Really makes me wonder about the projections of the total market of DMD in the range of billions, while the hopefully best in class treatment will be cheap if all goes well.

Good for the boys! Bad for my ego/retirement.